scholarly article | Q13442814 |
P50 | author | Lewis R. Roberts | Q38601327 |
P2093 | author name string | Ying Li | |
Gang Chen | |||
Charles D Smith | |||
Xiaoping Zou | |||
Frank A Sinicrope | |||
Roongruedee Chaiteerakij | |||
Catherine D Moser | |||
Melanie B Thomas | |||
Yanling Zhou | |||
Xiwei Ding | |||
Albert Ndzengue | |||
Shengbing Huang | |||
Jeffrey Boakye | |||
Hassan Shaleh | |||
P2860 | cites work | Drug combination studies and their synergy quantification using the Chou-Talalay method | Q29617422 |
Targeting sphingosine kinase induces apoptosis and tumor regression for KSHV-associated primary effusion lymphoma. | Q30408885 | ||
Autophagy is a survival mechanism of acute myelogenous leukemia precursors during dual mTORC2/mTORC1 targeting | Q33752594 | ||
Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2 | Q33755206 | ||
A novel sphingosine kinase inhibitor induces autophagy in tumor cells | Q33861997 | ||
Inhibition of active autophagy induces apoptosis and increases chemosensitivity in cholangiocarcinoma | Q33925154 | ||
Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2. | Q33936548 | ||
Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2. | Q34079007 | ||
Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma. | Q34209320 | ||
SPHK1 regulates proliferation and survival responses in triple-negative breast cancer | Q34227524 | ||
Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis. | Q34251293 | ||
Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase | Q34310422 | ||
SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma | Q34536227 | ||
Pathogenesis, diagnosis, and management of cholangiocarcinoma | Q34656747 | ||
Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2 | Q34891145 | ||
Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts | Q34928923 | ||
Combined anticancer effects of sphingosine kinase inhibitors and sorafenib | Q34949678 | ||
ABC294640, a sphingosine kinase 2 inhibitor, enhances the antitumor effects of TRAIL in non-small cell lung cancer | Q36216032 | ||
Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing | Q36388792 | ||
Identification of SPHK1 as a therapeutic target and marker of poor prognosis in cholangiocarcinoma. | Q36414244 | ||
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. | Q36627430 | ||
Biliary tract cancers in Olmsted County, Minnesota, 1976-2008. | Q36846561 | ||
The role of autophagy in cancer: therapeutic implications | Q37924056 | ||
Sphingosine 1-phosphate signalling in cancer | Q37977171 | ||
Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival | Q38424345 | ||
Inhibition of sphingosine kinase-2 ablates androgen resistant prostate cancer proliferation and survival | Q38987627 | ||
Targeting ovarian cancer and chemoresistance through selective inhibition of sphingosine kinase-2 with ABC294640. | Q39097511 | ||
Blocked autophagy using lysosomotropic agents sensitizes resistant prostate tumor cells to the novel Akt inhibitor AZD5363. | Q39222582 | ||
Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models | Q39242149 | ||
Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells | Q39589946 | ||
Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype | Q39823174 | ||
Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients | Q39881982 | ||
Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells | Q40345898 | ||
Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression | Q40423379 | ||
Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines | Q41464352 | ||
Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma | Q42045560 | ||
Autophagy in intra-hepatic cholangiocarcinoma | Q42080884 | ||
Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis | Q42799996 | ||
Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. | Q44503780 | ||
Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma. | Q53090136 | ||
Sphingosine kinase 2 promotes acute lymphoblastic leukemia by enhancing MYC expression. | Q54363475 | ||
Incidence and mortality trends for biliary tract cancers in Austria. | Q54774218 | ||
P433 | issue | 15 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | autophagy | Q288322 |
cholangiocarcinoma | Q124292 | ||
P304 | page(s) | 20080-20092 | |
P577 | publication date | 2016-04-01 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells | |
P478 | volume | 7 |
Q55001442 | A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors. |
Q61818544 | Diverse Functions of Autophagy in Liver Physiology and Liver Diseases |
Q42972395 | Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells |
Q37690896 | Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin |
Q90072359 | Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives |
Q56387433 | Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era |
Q41521563 | SKI-178: A Multitargeted Inhibitor of Sphingosine Kinase and Microtubule Dynamics Demonstrating Therapeutic Efficacy in Acute Myeloid Leukemia Models |
Q45072762 | Sphingosine Kinases/Sphingosine 1-Phosphate Signaling in Hepatic Lipid Metabolism. |
Q28069459 | Sphingosine-1 Phosphate: A New Modulator of Immune Plasticity in the Tumor Microenvironment |
Q97073430 | Targeting Sphingosine Kinase by ABC294640 against Diffuse Intrinsic Pontine Glioma (DIPG) |
Q90642085 | Targeting Sphingosine Kinases for the Treatment of Cancer |
Q64072869 | Targeting sphingosine kinase 2 suppresses cell growth and synergizes with BCL2/BCL-XL inhibitors through NOXA-mediated MCL1 degradation in cholangiocarcinoma |
Q47130227 | The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer. |
Q48349932 | The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo. |
Q58804941 | Typical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer Strategy |
Search more.